World’s Leading Neuroscientist –

Dr. Wise Young, founding director of the W.M. Keck Center for Collaborative Neuroscience and a distinguished professor, is recognized as one of the world’s outstanding neuroscientists.

Dr. Young is committed to bringing treatments to people with spinal cord Injuries. He built and trained a twenty-five center clinical trial network in China, Taiwan, and Hong Kong where human clinical trials using umbilical cord blood mononuclear cells and lithium are underway. In the initial results from the Phase II trial in Kunming, China, 75% of the participants (15 out of 20) recovered walking with a rolling walker. He is establishing clinical trial networks in the United States, Norway, and India and will start Phase IIB Trials in 2015 and Phase III trials in 2016.

Dr. Young led the team that discovered and established high-dose methylprednisolone (MP) as the first effective therapy for spinal cord injuries. This 1990 work upended concepts that spinal cord injuries were permanent, refocused research, and opened new vistas of hope. He also developed the first standardized rat spinal cord injury model used worldwide for testing therapies, formed the first consortium funded by the National Institutes of Health (NIH) to test promising therapies, and helped establish several widely accepted clinical outcome measures in spinal cord injury research.

Dr. Young is in high demand as a speaker at scientific conferences throughout the world and when media are in need of expert knowledge. His work was featured in a Life magazine special edition, USA Today, and innumerable national and international news and print publications. Some of his many honors include the Tall Texan Award, “Cure” Award, Trustees Award for Excellence in Research, Asian American Achievement Award, and the Douglass Medal for work with the advancement of young women in the sciences. He was the first researcher elected to the Spinal Cord Injury Hall of Fame. He was selected as the McGowen Distinguished Lecturer. Recently BioNJ recognized Dr. Young’s unique contributions by presenting him with their Patient Advocacy Award.   In 2006, the Richard H. Shindell Chair in Neuroscience was established at Rutgers University and Dr. Young was named as the first person to hold that chair. In an issue devoted to cutting edge work in science and medicine, TIME Magazine named Dr. Young as ‘America’s Best’ in spinal cord injury research.